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Introduction
The host-mediated assay was initially con-
ceived as a system for determining the
mutagenic potential of mammalian meta-
bolites of foreign compounds for bacteria
(1). In practice, a genetically defined in-
dicator microorganism is injected into the
peritoneal cavity of mice which are then
administered the substance under test, either
orally or parenterally. After a specified time
-usually 3 hr-the mouse is sacrificed and
the organisms are recovered; they are then
handled by standard bacteriological tech-
niques for determination of the mutant fre-
quency. An increase in the mutation fre-
quency above the solvent control indicates
an induction of mutation.
In order to further understand the re-
lationship between the host animal's meta-
bolic state and the mutagenic response of
the indicator microorganisms, the following
study was undertaken.
Three compounds were studied: two car-
cinogenic nitrosamines, dimethylnitrosamine
(DMNA) and N-nitrosomorpholine (NM),
which need metabolic activation for their
mutagenic and carcinogenic activities (1-7)
and the nitrosamide N-nitroso-N-methylurea
(NMU), which does not require metabolic
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activation for expression of its mutagenic
and carcinogenic properties (8-12).
The mice used as the host animals were
subjected to a number of nutritional vari-
ables, such as 24 hr starvation, an all-casein
diet, and a protein-free diet, which have
documented effects on DMNA metabolism.
In addition, the potent inhibitor of DMNA
metabolism, aminoacetonitrile (AAN), was
also employed, and the subsequent effects on
DMNA, NM, and NMU mutagenicity were
measured.
Reconstruction studies with tester strains
of the indicator microorganisms, in the
presence and absence of DMNA and AAN,
were performed to determine whether the
appearance of mutants in the host-mediated
assay was the result of a true mutational
phenomenon or whether it was simply a pro-
cess of selection for the preexisting mutants
in the population.
Materials and Methods
Strains
Salmonella typhimurium his G-46, a mis-
sense mutant, was obtained from Dr. Bruce
Ames, University of California, Berkeley.
S. typhimurium Z-34 (his+ met-) was de-
rived from S. typhimurium G-46 by spon-
taneous mutation.
Host-Mediated Assay
The host-mediated assay procedures em-
ployed were an adaptation of those previous-
December 1973 101ly published (1,7) and are presented in
more detail elsewhere (manuscript in pre-
paration).
The mice were injected IP with 2.0 ml
of a suspension of S. typhimurium G-46.
Where AAN was employed, it was in-
jected subcutaneously (SC) at this time at
a dose level of 200.0, 100.0, or 20.0 mg/kg.
One hour after the bacterial injection, the
mice were injected "intramuscularly (IM)
with DMNA (20.0 mg/kg), NM (100.0 mg/
kg), or NMU (10.0 mg/kg) in saline. The
mice were then sacrificed at intervals of 5,
10, 15, 20, 30, 60, and 120 min following
mutagen injection, and the bacteriological
procedures were performed as previously
described (7). The spontaneous reversion
frequency was determined at 120 min.
Results
Effects of Dietary Variables on the
Mutagenic Response
The mice maintained on a complete semi-
synthetic diet (SSD) for 6-8 days yielded
a depressed mutagenic response to both
DMNA and NM when compared to chow-fed
mice (Fig. 1). The response after DMNA in-
jection was depressed between 5 and 30 min
and attained a maximum at 60 min as op-
posed to the chow-fed maximum response
at 20 min. With the exception of the 5 min
value, the NM response, like the DMNA re-
sponse, suggests a depressed exposure of
the indicator organisms to the mutagenic
compound.
Overall, the effects observed with NMU
were contrary to the DMNA and NM re-
sults; the mean reversion frequencies at
most time intervals were higher in the
SSD-fed mice than in the chow-fed mice
(Fig. 1), but the differences between the
means were not significant (p>0.05).
Maintenance of the mice on a protein-
free diet for 8 days resulted in a dramatic
depression in the mutagenic response to
DMNA when compared to mice maintained
on SSD (20%o casein) (Fig. 2). NM, how-
ever, yielded an initial enhancement of mut-
agenicity followed by a depression (Fig. 3).
Starvation for 24 hr following SSD main-
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FIGURE 1. Comparison of the mutagenicity of (f)
20.0 mg/kg DMNA, (0) 100.0 mg/kg NM, and
(0) 10.0 mg/kg NMU, in chow ( ) and semi-
synthetic diet-fed (-) mice. Asterisks (*) denote
p<0.05 when compared to the corresponding chow
diet.
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FIGURE 2. Effects of (*) complete semisynthetic
diet, (O) protein-free diet (0) complete semi-
synthetic diet followed by 24-hr starvation and
(f) complete semisynthetic diet followed by 24-hr
casein diets on the mutagenicity of 20.0 mg/kg
DMNA for S. typhimurium G-46 in the mouse. sp.
denotes spontaneous reversion frequency; the as-
terisks (*) indicate p<0.05 when compared to
complete semisynthetic diet.
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FIGURE 3. Effects of (*) complete semisynthetic
diet, (EO) protein-free diet, (0) complete semi-
synthetic diet followed by 24-hr starvation, and
(v) complete semisynthetic diet followed by 24-hr
casein on the mutagenicity of 100.0 mg/kg NM for
S. typhimurium G-46 in the mouse. Asterisks(*),
sp. as in Fig. 2.
tenance produced an enhanced mutagenic
response to both DMNA (Fig. 2) and NM
(Fig. 3). The DMNA response, however,
following the initial enhancement, was de-
pressed at 60 and 120 min (Fig. 2). When
pure casein, alone, was fed to the mice for
24 hr following SSD feeding, both DMNA
(Fig. 2) and NM (Fig. 3) mutagenicity
were enhanced; DMNA to a greater extent
than NM.
When NMU was administered to mice
maintained on a protein-free diet, an er-
ratic response was obtained (Fig. 4). Feed-
ing pure casein alone for 24 hr following
SSD maintenance resulted in a dramatic
depression in the mutagenic response at all
time intervals (Fig. 4). The significantly
depressed response is strong evidence for
the involvement of a metabolic scheme which
has the capability of "detoxifying" NMU.
Effects of Aminoacetonitrile Pretreatment
on the Mutagenic Response
AAN, administered subcutaneously to the
mice 1 hr prior to the injection of DMNA
or NM depressed the mutagenic response at
all dose levels. The responses obtained with
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FIGURE 4. Effects of (e) complete semisynthetic
diet, (El) protein-free diet, (0) complete semi-
synthetic diet followed by 24-hr starvation, and
(X) complete semisynthetic diet followed by 24-hr
casein on the mutagenicity of 10.0 mg/kg NMU
for S. typhimurium G-46 in the mouse. Asterisks
(*), sp. as in Fig. 2.
DMNA appear dose-related (Fig. 5). The
gradual increases in mutation frequency ex-
hibited by 20.0 and 100.0 mg/kg indicate
that active mutagen is being released to the
cells in the peritoneal cavity at a depressed
rate as compared to the untreated mice;
the constant, low-level, mutagenic response
seen after 200.0 mg/kg AAN may be the
result not of liver metabolism, but of non-
hepatic activation of DMNA.
The absence of a dose-relationship in the
mice challenged with NM (Fig. 6) may be
related to the comparatively low mutagenic
response obtained in mice not treated with
AAN. Therefore, there may not be sufficient
latitude between the control NM mutation
level and the inhibited mutation levels to
effect a dose-related depression.
The level of AAN (200.0 mg/kg) that
caused the greatest inhibition of mutagenic
response with DMNA and NM yielded the
greatest enhancement of NMU mutagenicity
(Fig. 7). The expected corresponding dose
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FIGURE 5. Effects of AAN pretreatment on the
mutagenicity of 20.0 mg/kg DMNA for S. typhi-
murium G-46 in chow-fed mice: (Ol) AAN=
200.0mg/kg; (U) 100.0mg/kg; (Q) 20.0mg/kg;
(0) 0 mg/kg. Asterisks (*) denote p<0.05 when
compared to the next lowest AAN concentration.
effect with 100.0 and 20.0 mg/kg was not
seen; both doses yielded peak reversion
frequencies at 30 mmn. The higher mutant
frequency was elicited by 20.0 mg/kg; the
maximum mutant frequency seen with 100.0
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FIGURE 6. Effects of AAN pretreatn
mutagenicity of 100.0 mg/kg NM f
murium G-46 in chow-fed mice: (E)
mg/kg; (a) 100.0 mg/kg; (0) 20.0
- (0) 0 mg/kg.;Asterisks (*) denote I
compared to 0 mg/kg AAN.
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FIGURE 7. Effects of AAN pretreatment on the
mutagenicity of 10.0 mg/kg NMU for S. typhi-
murium G-46 in chow-fed mice: (5) AAN=200.0
mg/kg (U) 100.0 mg/kg; (0) 20.0 mg/kg; and
(e) 0 mg/kgfl Asterisks (*) denote p<0.05 when
compared to 0 mg/kg AAN.
mg/kg AAN, although displaced to 30 min,
was essentially equivalent to the control.
Reconstruction Studies
The ratios of his+ met-Ihis- met+
< (S. typhimurium Z-34/S. typhimurium G-
o 46) were significantly lower (p <0.05) than
the inoculum ratio at 120 min in the un-
_ < | treated group (Table 1). The ratios in
i the AAN group and the DMNA group did
not differ from the inoculum ratio (p >0.05).
AAN + DMNA treatment resulted in ratios
at 90 and 120 min. that were significantly
larger than the inoculum (p<0.05), imply-
ing selection for the his+ revertant.
The determination of the relationship be-
tween the treated groups and the inocula
60-n is predicated on the inoculum ratio which,
in this experimental design, is a constant,
ient on the lacking variance. The lack of variance, in
or S. typhi- all probability, is the major factor in the AmAN=20a0.0 significance of the AAN and DMNA values.
<0.05 when In any event, there was no effect over the
entire time span of the experiments that
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104Table 1. Ratios of S. typhimurium hi8+ met- to S. typhimurium his- met+ (X 101) recovered
from the peritoneal cavity of the mouse.
Time after
inoculation Ratios a
of cell
suspension, Control AAN DMNA AAN +
min DMNA
0 (Inoculum) 1.99 b 1.28 1.82 1.45
60 min 1.91 1.21 1.61 d 1.70 d
(1.70-2.13) (0.76-1.54) (1.40-1.89) (1.34-2.17)
90 min 1.79 1.32 1.80 1.70 e
(1.55-2.06) (1.17-1.61) (1.26-2.40) (1.53-1.92)
120 min 1.69 e 1.35 2.09 1.55 e
(1.54-1.84) (1.16-1.55) (1.78-2.46) (1.48-1.62)
180 min 2.03 1.57 1.82 1.77
(1.60-2.67) (1.16-2.06) (1.51-2.12) (1.41-2.09)
' Z-34/G-46.
b Mean ratio.
e 95% confidence limits.
d Without DMNA.
e p <0.05 when compared to inoculum.
indicated a selective advantage or disad-
vantage being conferred upon either the
his+ revertant or the parent S. typhimur-
ium G-46.
Discussion
The mutagenicity of a number of car-
cinogenic nitrosamines for S. typhimurtium
G-46 in the host-mediated assay have been
previously reported (1,2,5,7,13). There still
remained the need, however, to demonstrate
that in vivo mutagenicity in the host-medi-
ated assay is truly linked to the metabolic
state of the host and not merely to the
physical presence of the cells in the animal,
and to show that the host-mediated assay can
be utilized as a tool to study the metabolism
of compounds that are mutagenic.
The results presented here, while not
directly indicative of metabolism, demon-
strate that factors known to affect the met-
abolism of DMNA in test animals can also
influence its mutagenicity in the host-med-
iated assay, as well as the mutagenicity of
the related N-nitroso compounds, NM and
NMU.
The reconstruction studies demonstrate
that the appearance of his+ revertants of
S. typhimurium G-46 in the host-mediated
assay is a mutagenic effect rather than the
result of selection in the mouse peritoneal
cavity (Table 1) and imply that AAN pre-
treatment depresses DMNA mutagenicity
by acting on its metabolism and not on-
the indicator bacteria.
The significant inhibition of DMNA and
NM metabolism by AAN (Figs. 5 and 6)
corresponds to the reported inhibitory ef-
fects of AAN on DMNA breakdown in rats
and its resulting toxic and lethal manifesta-
tions (14-18). The depressed DMNA muta-
tion frequency seen at AAN levels of 20.0
and 100.0 mg/kg, indicates a greatly de-
creased formation (or release) of active mut-
agens to the indicator cells in the peritoneal
cavity.
An interesting effect is the -'significant
difference in the mutagenic responses to
DMNA and NM in mice fed a complete
semisynthetic diet in place of the com-
mercial chow (Fig. 1). This enhancement
of nitrosamine activity by a chow diet had
not heretofore been reported, but- Brown et
al. (19) found that mice and rats fed chow
diets had a higher level of .3-methyl-4-mono-
methylaminoazobenzene N-demethylase activ-
December 1973 105ity than animals fed purified diets. Holtzman
and Gillette (20) demonstrated an increased
level of aniline hydroxylase activity in male
rats fed purified diets as compared to chow;
but enzyme activity in female rats was un-
affected by diet. Marshall and McLean (21)
observed that male rats fed a semisynthetic
diet had a decreased liver P-450 concentra-
tion when compared to rats fed a chow diet.
Friedman and Yin (22) reported that the
metabolism of aflatoxin B1 and dimethyl-
aminopyrine in liver slices from male rats
maintained on a chow diet was higher than
in liver slices from rats maintained on a semi-
synthetic diet. In addition, McLean and Mc-
Lean (23) observed an increase in the oral
LD50 of carbon tetrachloride in male rats fed
a semisynthetic (30%o casein) diet as op-
posed to a stock (chow) diet.
These results demonstrated that the types
of diet employed when studying the metab-
olism and the in vivo effects of N-nitrosa-
mines, and of other classes of compounds as
well, may be an important consideration
in the interpretation of the effects reported
in the literature.
On the basis of these observations, studies
regarding the metabolic effects of protein-
free (or other variable) diets should be re-
lated to complete semisynthetic diets only,
and not to commercial chow diets, as has
been done in a number of studies (23-25).
For example, an apparent inhibitory effect
seen in animals fed a protein-free (semi-
synthetic) diet when compared to a chow
diet, also might be present if a 20%o casein
(complete semisynthetic) diet were compared
to a chow diet.
The depression of DMNA mutagenicity
found in protein-depleted mice (Fig. 2) par-
allels the depression of DMNA metabolism
and toxicity previously reported (11,21,26).
NM, however, does not present a. clear pic-
ture, an apparent initial enhancement fol-
lowed by a depression (Fig. 3). This may be
an indication that NM is metabolized by an
enzyme system which is independent of
DAINA.N-demethylase.
The data also demonstrate that the en-
hancement of DMNA N-demethylation by
rats, in vitro, following 24 hr starvation or
24 hr casein feeding, as found by Venkate-
san et al. (27,28) parallels the enhance-
ment of its mutagenicity in the host-mediated
assay, although the starvation-induced en-
hancement only occurred during the initial
30 min and was followed by a depression.
The effects reported here can only be re-
lated to metabolism in the mouse by in-
ference, since the corresponding metabolic
studies were not performed.
NM mutagenicity was likewise enhanced
by both dietary regimens, which would in-
dicate that its metabolism is similarly af-
fected (Fig. 3). One would like to see the
NM mutagenicity data parallel that of
DMNA; 20%o casein inducing a higher level
of reversion than 24 hr starvation. That this
is not the situation may simply be a reflection
that the low level of reversion induced by
NM, when compared to DMNA, is unsuit-
able for determination of relatively small
effects.
Another possible explanation for the rel-
ative insensitivity of NM in situations which
generate a marked response in DMNA and
NMU mutagenicity might be derived from
its dose-response curve. It can be seen (Fig.
8) that the mutagenicity of NM with respect
to dose exhibits a gradual rise at the dose
level employed (100.0 mg/kg) as opposed to
the rapid increases of DMNA (at 20.0 mg/
kg) and NMU (at 10.0 mg/kg). Because of
this, a change in the effective concentration of
NM by either depressing or enhancing its
in vivo metabolism, would not markedly
alter the mutagenic response of S. typhi-
murium G-46. DMNA and NMU, on the
other hand, would exhibit relatively large
responses to minor changes in their effec-
tive concentrations at the dose levels em-
ployed.
The results obtained with NMU in these
studies indicate that it did not respond as
an unmetabolized control would be expected
to. It can be seen that, with the exception
of 24 hr starvation, NMU appears to respond
in a contrary manner to DMNA and NM:
that is, when their mutagenicity is inhibited,
NMU mutagenicity is enha-nced and vice
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FIGUR.E 8. Mutagenicity of (0) DMNA, (m) NM,
and (A) NMU for S. typhimurium G-46 in the
host-mediated assay.
versa. The prolonged mutagenic response
seen with AAN treatment and the no-protein
diet, while not as clear cut as the inhibition
of DMNA, nevertheless, is definitely an en-
hanced response, possibly due to a lengthened
half life of NMU in the mouse.
Also, the marked depression elicited by
the 24 hr casein diet which enhances DMNA
and NM metabolism and mutagenicity is
clearly an inhibition of NMU activity. The
apparent detoxification of NMU may be a
result of the capability of the liver micro-
somal oxidase system to metabolize NMU
to a nonmutagenic form. Therefore, con-
ditions which enhance its activity, and the
mutagenicity of DMNA, such as a 24-hr
casein diet, would coincidentally accelerate
the breakdown of NMU to a nonmutagenic
form. Alternately, depression of this system,
by pretreating the mice with AAN or a
protein-free diet, could prolong the half
life of the mutagenically-active parent com-
pound, NMU. Whatever the mechanism, the
data demonstrate the ability of the meta-
bolically competent mouse to detoxify a
mutagenic substance in vivo.
The host-mediated assay, because of its
design, is relatively insensitive. The proximal
mutagen must reach the indicator micro-
organisms in the peritoneal cavity in suf-
ficient quantity to produce a positive re-
sponse. Obviously, a large number of factors
contribute to the mutagenicity-or lack of
mutagenicity-of a compound in the host-
mediated assay. These factors are the sum
of all the processes which affect the avail-
ability of an active compound to the in-
dicator bacteria in the peritoneal cavity.
They include: metabolism; tissue distribu-
tion; permeability of cell membranes; en-
vironmental factors such as nutrition and
maintenance conditions; and genetic fac-
tors such as animal species, strain and sex.
A change in any one of these factors may
be sufficient to significantly affect the ob-
served mutagenic response to a specific
chemical or class of chemicals.
In addition, a highly active compound may
interact with the body tissues so that suffi-
cient active compound might not be avail-
able to the peritoneal cavity. The compound
may also be too toxic to allow an adequate
dose to be given the host animal so that
a mutagenic dose can be distributed to the
indicator microorganisms. These effects have
been observed with both alkylating and in-
tercalating agents (E. Zeiger, unpublished
data).
This provides a rationale for bypassing
the host mediated assay with compounds
active in vitro. If a substance is mutagenic
in vitro and also in the host-mediated assay,
no new information is gained from the in
vivo data since comparative in vitro-in vivo
quantitation is not possible. On the other
hand, if a compound active in vitro is not
active or only marginally active in vivo,
a number of explanations are possible, as
described above. The concept of metabolic
"detoxification", while attractive, is not in-
dicated in the absence of additional informa-
December 1973 10f7tion. As has been demonstrated with NMU,
detoxification probably is manifested as a
quantitive change rather than an all-or-none
effect.
The results described here have been in-
terpreted primarily as they might relate to
the liver microsomal enzyme system and
specifically the oxidative enzymes. Alterna-
tively, the nitrosamines could be metabolized
in the liver by additional mechanisms which
may not be associated with the microsomal
fraction or with the liver. They may also
be anaerobically metabolized to the cor-
responding hydrazides, as was demonstrated
for NM by Suss, using a guinea pig liver
homogenate under No (29). The mutagenic
and carcinogenic effects of a number of
hydrazides (30-34) suggest consideration of
this alternative.
This is why it is important to relate the
mutagenicity of a chemical in the host-
mediated assay to the host's metabolic capa-
bilities as defined by in vivo and in vitro
enzyme studies. In fact, this should be a
general principle with regard to all in vivo
toxicological effects, as pointed out by Burns
et al. (9) when attempting to calculate
"no-effect" levels in laboratory animals and
humans. This concept has been domonstrated
by the Weisburgers (35) with regard to
carcinogens, i.e., that the "no-effect" level
in any carcinogenic study is a function of
the test system employed, and an alteration
in this artificial test system can, and does,
reflect an alteration in the dose-response
of the animals under test.
This phenomenon has now been demon-
strated in regard to the mutagenicity of N-
nitroso compounds in the host-mediated as-
say. While no attempt was made to obtain a
no-effect level in any of the metabolic sys-
tems used, it is obvious that the formation
(or the persistence) of the proximal mu-
tagens, in vivo, can be affected by alteration
of the animals' nutritional state, or by
chemical means. Therefore, if a no-effect
level for the host-mediated assay response
to these compounds is derived, it must be
under well-defined conditions, with the under-
standing that it is not an immutable value.
These results also show, when interpreted
in light of the available literature, that the
formation of the proximal mutagenic de-
rivative of DMNA parallels the formation
of its proximal carcinogenic and hepatotoxic
derivatives. This leads to the conclusion that
all three in vivo effects of DMNA: muta-
genicity, carcinogenicity, and hepatotoxicity,
may be responses to the same chemical sub-
stance. Unfortunately, a similar statement
cannot be made at this time regarding NM
and NMU, since their metabolism has not
been adequately studied. However, their mut-
agenic responses in the host-mediated as-
say, following various treatments of the
mice, have predictive value for long-term
toxicity and carcinogenicity studies.
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